Companies

IVMD uses its proven, patented core technology to design, develop and test medical devices for near patient testing and monitoring. IVMD is focused on minimal sample sizes or completely non-invasive sampling where it brings its skills in electronics and physics to improve on the detection methods previously developed by biologists and chemists. IVMD is noted for providing a fast track route to get new products to market.

The company's highly sensitive magnetic measurement system has already been commercialised to produce a device for measuring the coagulation of blood in patients at risk of heart disease and stroke. The magnetic particle detection technology is close to commercialisation for an ultra sensitive, low cost immunoassay platform for point-of-care applications providing quantitative results down to the femtomolar level. The Data capture and complex signal analysis algorithms that predict the onset of mamallian labour 3 days in advance of the event. The method is being adapted for use with horses and other animals.

On August 1, 2006, UTEK Corporation (AMEX:UTK - News; LSE-AIM:UTK), a specialty finance company focused on technology transfer, and
In Veritas Medical Diagnostics (OTCBB:IVME - News), a novel medical device company, are pleased to announce that they have signed a strategic alliance agreement.

Graham Cooper (President and Chief Executive Officer)
Mr. Cooper is a successful business entrepreneur of £110M turnover company and he is also the chairman of a number of technology companies.

Martin Thorp (Chief Financial Officer)
Mr. Thorp is also the ex managing partner of Arthur Anderson global M&A.

Damian Bond (Commercial Manager)
Mr. Bond's experience spans 18 years commercialising diagnostics, including Life Sciences, Consumer Marketing, Doctor's Office, Clinical, Food, and Environmental sectors on an international basis.

John Fuller (Non Executive Strategic Advisor)
Mr. Fuller has a commercial / product development background in a number of high technology based OEM's. He also run businesses up to £220 M turnover and successfully atttracted high technology programs up to £50M.